Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

Commission gives a warm welcome to unregistered lobbyists: Dalli not alone in ignoring transparency

Ex-Commissioner John Dalli knowingly met with lobbyists who were not registered in the European Commission and European Parliament’s Transparency Register. Lobbyists who choose to hide from the public who they're lobbying for, on what subject, or how much money they’re spending to influence public policy. Lobbyists who work in the shadows. Shocking? Yes, but it is a very common practice in the Commission to meet with unregistered lobbyists, a sure-fire indicator that despite what it says, the Commission is not really concerned about lobby transparency.

Dalli, defending the role of Maltese acquaintances acting as middlemen between himself and international organisations, admitted that they are not usually registered. But do other Commissioners meet with unregistered interest representatives?

Consider, for example, European Commission Vice-President, and Commissioner for Economic and Monetary Affairs, Olli Rehn. 62% of the meetings that the Commissioner responsible for macroeconomic stability had between January 2011 to February 2012, were with unregistered bodies, including three meetings with unregistered global banking giant Goldman Sachs. Of the 34 organisations that Rehn reports having met, the overwhelming majority – 22 (65%) – were not registered in the Transparency Register.*

The Commission is convinced that there is no room for improvement in the transparency of its processes. At the dawn of Dalligate, a Commission spokesperson said “of course there are – following very clear practices and rules - contacts between stakeholders and Commissioners, that is normal practice”. And yet it is evident that these ‘very clear practices and rules’ do not include guidelines for Commissioners to refuse meeting unregistered lobbyists.

The inevitable conclusion is that whilst the Commission maintains that the events around the Dalli case (which, they say, is closed) show that the EU's anti-corruption system works”, the very opposite appears to be true. Dalligate is more than just a scandal about one Commissioner, one lobbyist and one tobacco company. Dalligate is a symptom of a wider problem.

* This is based on a list of Commissioner Rehn’s meetings between January 2011 and February 2012, released to CEO by the Commission in September 2012 . The organisations met by Rehn were then cross-referenced with the organisations listed in the Transparency Register (accessed 30 October 2012). It should be noted that there is some ambiguity as to what were meetings (which the content of this list is entitled), as in one place the Commission uses the label “Meeting or Received Letter”.

Dalli, defending the role of Maltese acquaintances acting as middlemen between himself and international organisations, admitted that they are not usually registered. But do other Commissioners meet with unregistered interest representatives?Consider, for example, European Commission Vice-President, and Commissioner for Economic and Monetary Affairs, Olli Rehn. 62% of the meetings that the Commissioner responsible for macroeconomic stability had between January 2011 to February 2012, were with unregistered bodies, including three meetings with unregistered global banking giant Goldman Sachs. Of the 34 organisations that Rehn reports having met, the overwhelming majority – 22 (65%) – were not registered in the Transparency Register.*The Commission is convinced that there is no room for improvement in the transparency of its processes. At the dawn of Dalligate, a Commission spokesperson said “of course there are – following very clear practices and rules - contacts between stakeholders and Commissioners, that is normal practice”. And yet it is evident that these ‘very clear practices and rules’ do not include guidelines for Commissioners to refuse meeting unregistered lobbyists.The inevitable conclusion is that whilst the Commission maintains that the events around the Dalli case (which, they say, is closed) “show that the EU's anti-corruption system works”, the very opposite appears to be true. Dalligate is more than just a scandal about one Commissioner, one lobbyist and one tobacco company. Dalligate is a symptom of a wider problem.* This is based on a list of Commissioner Rehn’s meetings between January 2011 and February 2012, released to CEO by the Commission in September 2012 . The organisations met by Rehn were then cross-referenced with the organisations listed in the Transparency Register (accessed 30 October 2012). It should be noted that there is some ambiguity as to what were meetings (which the content of this list is entitled), as in one place the Commission uses the label “Meeting or Received Letter”.
 

Comments

Power corrupts, and as everyone knows, absolute power corrupts absolutely. The way things are going in Europe the European Commission is getting more powerful every day. No wonder that commissioners are delectable titbits for lobbyists.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Commission refuses to act on the recommendations of the European Ombudsman regarding tobacco industry lobbying.

CEO turns the spotlight on another of the interest groups operating within the European Parliament.

The voice of the Dutch Government has been loud and clear in Brussels on the issue of cisgenic plants. The Dutch have waged a sustained campaign to have new GM techniques – and in particular cisgenesis – excluded from EU GMO regulations. Several Dutch ministries, the Dutch Parliament, the Dutch Permanent Representation in Brussels, and Dutch MEPs have energetically pursued this goal.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

Commission refuses to act on the recommendations of the European Ombudsman regarding tobacco industry lobbying.

CEO turns the spotlight on another of the interest groups operating within the European Parliament.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

The biotech industry is staging an audacious bid to have a whole new generation of genetic engineering techniques excluded from European regulations. The pending decision of the European Commission on the regulation of these so-called 'new GMOs' represents a climax point in the ongoing below-the-radar attack by industry on GM laws.

The corporate lobby tour

Stop the Crop

Alternative Trade Mandate